Brookstone Capital Management Viatris Inc Transaction History

Brookstone Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$10.32 - $12.13 $3,797 - $4,463	368 Added 2.83%	13,379 $155,000
Q2 2024 Jul 18, 2024	BUY	$10.05 - $12.02 $3,879 - $4,639	386 Added 3.06%	13,011 $138,000
Q1 2024 Apr 15, 2024	SELL	$11.27 - $13.53 $42,949 - $51,562	-3,811 Reduced 23.19%	12,625 $150,000
Q4 2023 Jan 11, 2024	BUY	$8.77 - $10.85 $144,143 - $178,330	16,436 New	16,436 $178,000
Q1 2023 Apr 18, 2023	SELL	$9.2 - $12.26 $42,237 - $56,285	-4,591 Reduced 25.74%	13,246 $127,000
Q4 2022 Jan 09, 2023	BUY	$8.72 - $11.56 $155,538 - $206,195	17,837 New	17,837 $0
Q1 2021 Apr 16, 2021	SELL	$13.59 - $18.54 $156,570 - $213,599	-11,521 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$14.3 - $18.74 $164,750 - $215,903	11,521 New	11,521 $216,000

1,136

953M

4.15M

2.65M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.